Search News Releases
-
Mixed results on early human testing of iron chelation after brain bleed
Study Highlight: Removing iron and toxins from the body after a brain bleed had little effect on intracerebral hemorrhage stroke recovery at three months but might have potential benefits at six months.
-
At-home rehab comparable to clinic-based therapy to improve mobility
Study Highlight: Home-based telerehabilitation is as effective as clinic-based therapy at improving arm function,
-
Intensive blood pressure lowering safe for clot-buster-treated stroke patients, but doesn’t lessen disability
Study Highlight: Rapidly lowering blood pressure beyond recommended targets safely reduced the risk of bleeding as a side effect in stroke patients but did not limit post-stroke disability.
-
Reversal agent decreases life-threatening bleeding
Study Highlight: The blood thinner reversal agent – andexanet alfa –was effective at stopping acute major bleeding in patients taking factor Xa inhibitor blood thinners.
-
Size and time impact outcomes when mechanical clot removal used for large core strokes
Study Highlights: Patient outcomes with large core stroke damage are worse the larger the core volume and the longer the time lapse between stroke onset and treatment. Perfusion imaging may help identify large core stroke patients who are potential...
-
Minimally-invasive surgery for brain bleeds may not be better at restoring function than standard meds, but may lessen deaths
Study Highlight: MISTIE III trial finds surgery for brain bleeding may not be better than medical treatment in restoring function but was better at reducing the risk of death.
-
Removing more blood via minimally invasive surgery more likely to improve hemorrhagic stroke recovery
Study Highlight: The greater the volume of blood removed from the brain via minimally invasive surgery after a hemorrhagic stroke the greater the odds of better functional recovery.
-
Target: Stroke program demonstrates substantially improved outcomes in adherence to stroke care guidelines; phase III kicks off
Highlights: There was substantial further improvement in time to alteplase administration in GWTG-Stroke hospitals after implementation of Target: Stroke Phase II achieving door-to-needle times within 60 minutes for 75 percent or more of acute ischemic stroke patients. Target: Stroke Phase II was associated with improvements in clinical outcomes for patients with acute ischemic stroke.
-
Study shows need for Thrombectomy-capable Stroke Centers remains high in 64 percent of communities studied
Highlights: The need for Thrombectomy-capable Stroke Centers (TSC) certification remains high as the study finds 64 percent of areas are classified as very high/high need areas due to a maximum drive time of 30 minutes.
-
Intense IV blood sugar control doesn’t improve stroke outcomes
Study Highlight: Intense IV insulin is not better than standard insulin shots at improving stroke recovery.
